PNC Financial Services Group
MBX

PNC Financial Services Group’s MBX Biosciences MBX Stock Holding History

PNC Financial Services Group’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Hold
207
– – ﹤0.01% 4028
2026
Q1 		$6.18K Buy
207
+11
+6% +$374 ﹤0.01% 4169
2025
Q4 		$6.18K Sell
196
-56
-22% -$1.36K ﹤0.01% 4148
2025
Q3 		$4.41K Buy
+252
New +$3.37K ﹤0.01% 4250

Other funds holding MBX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

PNC Financial Services Group's MBX Position: Q2 2026 in Review

PNC Financial Services Group held its MBX Biosciences (MBX) position steady in Q2 2026 at 207 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4028.

PNC Financial Services Group first reported a position in MBX in Q3 2025 and has held it in 4 quarters since. 44 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • PNC Financial Services Group held 207 shares of MBX Biosciences worth $11.4K as of Q2 2026.
  • PNC Financial Services Group left its MBX Biosciences share count unchanged in Q2 2026.
  • MBX Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4028 holding.
  • PNC Financial Services Group first reported a position in MBX Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 44 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.